Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Pockets $3.7M in Stock Sale; Will Pay for Vilazodone, Other Projects

NEW YORK (GenomeWeb News) — Clinical Data today said that affiliates of company chairman RJ Kirk exercised warrants for $3.7 million in shares.
 
The purchase for 190,505 shares of the company’s common stock, valued at $19.45 a share, came from warrants issued in June 2006, the company said.
 
Clinical Data President and CEO Drew Fromkin said the cash “strengthens the company’s balance sheet and provides additional liquidity” to support the third phase of clinical trials for Vilazodone, among other projects.
 
The company may also use the cash to invest in new technology development, new IP, and “other strategic assets,” Ballantyne added.
 
The extra money will “substantially enhance shareholder value in the event of positive Phase III results,” said senior vice president and CFO Evan Ballantyne.
 
Ballantyne said the company expects that value to increase if it manages to identify genetic markers for use in a Vilazodone companion diagnostic test. 

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.